Empowered Patient Podcast

Mid-Size CRO Offers Flexibility Collaboration and AI Tools to Transform Clinical Trials with Dr. Philip Räth Palleos Healthcare

Informações:

Synopsis

Dr. Philip Räth, Managing Director at Palleos, discusses the advantages of a mid-size contract research organization compared to a large CRO. Customized solutions, strong cross-departmental cooperation, and fast decision-making are key to addressing the most significant unmet needs of clinical trial sponsors. This nimble clinical trial model, supported by machine learning, emphasizes collaboration and transparency. Philip explains, "In the end, we are a service industry, so it's always about time, costs, and quality. So, certain structures have been established in terms of project management and how you set up trials. We have regulations in place that are very clear on how things should get done. So, I think what collaboration enables is getting something done together. Collaboration between sponsors and CROs can transform the landscape and situation where collaboration enables trust and, therefore, change is possible." "I think that's always the biggest challenge for collaboration. You have change in the pro